nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP2C19—Rosuvastatin—atherosclerosis	0.116	0.195	CbGbCtD
Esomeprazole—CYP2C19—Simvastatin—atherosclerosis	0.108	0.181	CbGbCtD
Esomeprazole—CYP2C19—Lovastatin—atherosclerosis	0.105	0.177	CbGbCtD
Esomeprazole—CYP3A4—Rosuvastatin—atherosclerosis	0.0559	0.0941	CbGbCtD
Esomeprazole—CYP3A4—Ezetimibe—atherosclerosis	0.0559	0.0941	CbGbCtD
Esomeprazole—CYP3A4—Simvastatin—atherosclerosis	0.052	0.0875	CbGbCtD
Esomeprazole—CYP3A4—Lovastatin—atherosclerosis	0.0509	0.0857	CbGbCtD
Esomeprazole—CYP3A4—Pravastatin—atherosclerosis	0.0509	0.0857	CbGbCtD
Esomeprazole—CYP3A4—Irinotecan Pathway—NPC1—atherosclerosis	0.000716	0.0618	CbGpPWpGaD
Esomeprazole—Tinnitus—Niacin—atherosclerosis	0.000539	0.00137	CcSEcCtD
Esomeprazole—Erythema multiforme—Pravastatin—atherosclerosis	0.000538	0.00137	CcSEcCtD
Esomeprazole—Dysgeusia—Simvastatin—atherosclerosis	0.000537	0.00136	CcSEcCtD
Esomeprazole—Flushing—Niacin—atherosclerosis	0.000537	0.00136	CcSEcCtD
Esomeprazole—Angioedema—Lovastatin—atherosclerosis	0.000535	0.00136	CcSEcCtD
Esomeprazole—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000533	0.00135	CcSEcCtD
Esomeprazole—Anaemia—Ezetimibe—atherosclerosis	0.000531	0.00135	CcSEcCtD
Esomeprazole—Tinnitus—Pravastatin—atherosclerosis	0.000531	0.00135	CcSEcCtD
Esomeprazole—Malaise—Lovastatin—atherosclerosis	0.000528	0.00134	CcSEcCtD
Esomeprazole—Flushing—Pravastatin—atherosclerosis	0.000528	0.00134	CcSEcCtD
Esomeprazole—Muscle spasms—Simvastatin—atherosclerosis	0.000527	0.00134	CcSEcCtD
Esomeprazole—Vertigo—Lovastatin—atherosclerosis	0.000526	0.00134	CcSEcCtD
Esomeprazole—Angioedema—Ezetimibe—atherosclerosis	0.000525	0.00133	CcSEcCtD
Esomeprazole—Leukopenia—Lovastatin—atherosclerosis	0.000525	0.00133	CcSEcCtD
Esomeprazole—Chills—Niacin—atherosclerosis	0.000519	0.00132	CcSEcCtD
Esomeprazole—Malaise—Ezetimibe—atherosclerosis	0.000518	0.00131	CcSEcCtD
Esomeprazole—Vision blurred—Simvastatin—atherosclerosis	0.000517	0.00131	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000514	0.0013	CcSEcCtD
Esomeprazole—Tremor—Simvastatin—atherosclerosis	0.000514	0.0013	CcSEcCtD
Esomeprazole—Alopecia—Niacin—atherosclerosis	0.000511	0.0013	CcSEcCtD
Esomeprazole—Chills—Pravastatin—atherosclerosis	0.000511	0.0013	CcSEcCtD
Esomeprazole—Insomnia—Rosuvastatin—atherosclerosis	0.00051	0.00129	CcSEcCtD
Esomeprazole—Ill-defined disorder—Simvastatin—atherosclerosis	0.000509	0.00129	CcSEcCtD
Esomeprazole—Palpitations—Ezetimibe—atherosclerosis	0.000508	0.00129	CcSEcCtD
Esomeprazole—Paraesthesia—Rosuvastatin—atherosclerosis	0.000507	0.00129	CcSEcCtD
Esomeprazole—Anaemia—Simvastatin—atherosclerosis	0.000507	0.00129	CcSEcCtD
Esomeprazole—Malnutrition—Niacin—atherosclerosis	0.000503	0.00128	CcSEcCtD
Esomeprazole—Alopecia—Pravastatin—atherosclerosis	0.000503	0.00128	CcSEcCtD
Esomeprazole—Cough—Ezetimibe—atherosclerosis	0.000502	0.00127	CcSEcCtD
Esomeprazole—Angioedema—Simvastatin—atherosclerosis	0.000501	0.00127	CcSEcCtD
Esomeprazole—Chest pain—Lovastatin—atherosclerosis	0.000499	0.00127	CcSEcCtD
Esomeprazole—Myalgia—Lovastatin—atherosclerosis	0.000499	0.00127	CcSEcCtD
Esomeprazole—Arthralgia—Lovastatin—atherosclerosis	0.000499	0.00127	CcSEcCtD
Esomeprazole—Anxiety—Lovastatin—atherosclerosis	0.000497	0.00126	CcSEcCtD
Esomeprazole—Dyspepsia—Rosuvastatin—atherosclerosis	0.000497	0.00126	CcSEcCtD
Esomeprazole—Hypertension—Ezetimibe—atherosclerosis	0.000496	0.00126	CcSEcCtD
Esomeprazole—Flatulence—Niacin—atherosclerosis	0.000496	0.00126	CcSEcCtD
Esomeprazole—Malaise—Simvastatin—atherosclerosis	0.000494	0.00125	CcSEcCtD
Esomeprazole—Tension—Niacin—atherosclerosis	0.000494	0.00125	CcSEcCtD
Esomeprazole—ATP4B—Ion channel transport—TRPV1—atherosclerosis	0.000493	0.0426	CbGpPWpGaD
Esomeprazole—Discomfort—Lovastatin—atherosclerosis	0.000493	0.00125	CcSEcCtD
Esomeprazole—Vertigo—Simvastatin—atherosclerosis	0.000492	0.00125	CcSEcCtD
Esomeprazole—CYP3A4—Liver X Receptor Pathway—ABCG8—atherosclerosis	0.000492	0.0425	CbGpPWpGaD
Esomeprazole—Leukopenia—Simvastatin—atherosclerosis	0.000491	0.00124	CcSEcCtD
Esomeprazole—Arthralgia—Ezetimibe—atherosclerosis	0.000489	0.00124	CcSEcCtD
Esomeprazole—Chest pain—Ezetimibe—atherosclerosis	0.000489	0.00124	CcSEcCtD
Esomeprazole—Myalgia—Ezetimibe—atherosclerosis	0.000489	0.00124	CcSEcCtD
Esomeprazole—Nervousness—Niacin—atherosclerosis	0.000489	0.00124	CcSEcCtD
Esomeprazole—Flatulence—Pravastatin—atherosclerosis	0.000488	0.00124	CcSEcCtD
Esomeprazole—Dry mouth—Lovastatin—atherosclerosis	0.000488	0.00124	CcSEcCtD
Esomeprazole—Tension—Pravastatin—atherosclerosis	0.000486	0.00123	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000486	0.00123	CcSEcCtD
Esomeprazole—Dysgeusia—Pravastatin—atherosclerosis	0.000485	0.00123	CcSEcCtD
Esomeprazole—Muscle spasms—Niacin—atherosclerosis	0.000484	0.00123	CcSEcCtD
Esomeprazole—Discomfort—Ezetimibe—atherosclerosis	0.000483	0.00123	CcSEcCtD
Esomeprazole—Pain—Rosuvastatin—atherosclerosis	0.000483	0.00122	CcSEcCtD
Esomeprazole—Constipation—Rosuvastatin—atherosclerosis	0.000483	0.00122	CcSEcCtD
Esomeprazole—Confusional state—Lovastatin—atherosclerosis	0.000482	0.00122	CcSEcCtD
Esomeprazole—Nervousness—Pravastatin—atherosclerosis	0.000481	0.00122	CcSEcCtD
Esomeprazole—Dry mouth—Ezetimibe—atherosclerosis	0.000479	0.00121	CcSEcCtD
Esomeprazole—Anaphylactic shock—Lovastatin—atherosclerosis	0.000478	0.00121	CcSEcCtD
Esomeprazole—Muscle spasms—Pravastatin—atherosclerosis	0.000476	0.00121	CcSEcCtD
Esomeprazole—Infection—Lovastatin—atherosclerosis	0.000475	0.00121	CcSEcCtD
Esomeprazole—Vision blurred—Niacin—atherosclerosis	0.000474	0.0012	CcSEcCtD
Esomeprazole—Confusional state—Ezetimibe—atherosclerosis	0.000473	0.0012	CcSEcCtD
Esomeprazole—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000469	0.00119	CcSEcCtD
Esomeprazole—Thrombocytopenia—Lovastatin—atherosclerosis	0.000468	0.00119	CcSEcCtD
Esomeprazole—Vision blurred—Pravastatin—atherosclerosis	0.000467	0.00118	CcSEcCtD
Esomeprazole—Myalgia—Simvastatin—atherosclerosis	0.000467	0.00118	CcSEcCtD
Esomeprazole—Arthralgia—Simvastatin—atherosclerosis	0.000467	0.00118	CcSEcCtD
Esomeprazole—Chest pain—Simvastatin—atherosclerosis	0.000467	0.00118	CcSEcCtD
Esomeprazole—Infection—Ezetimibe—atherosclerosis	0.000466	0.00118	CcSEcCtD
Esomeprazole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000465	0.00118	CcSEcCtD
Esomeprazole—Anxiety—Simvastatin—atherosclerosis	0.000465	0.00118	CcSEcCtD
Esomeprazole—Tremor—Pravastatin—atherosclerosis	0.000464	0.00118	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000461	0.00117	CcSEcCtD
Esomeprazole—Discomfort—Simvastatin—atherosclerosis	0.000461	0.00117	CcSEcCtD
Esomeprazole—Nervous system disorder—Ezetimibe—atherosclerosis	0.00046	0.00117	CcSEcCtD
Esomeprazole—Angioedema—Niacin—atherosclerosis	0.00046	0.00117	CcSEcCtD
Esomeprazole—Ill-defined disorder—Pravastatin—atherosclerosis	0.00046	0.00117	CcSEcCtD
Esomeprazole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000459	0.00116	CcSEcCtD
Esomeprazole—Anaemia—Pravastatin—atherosclerosis	0.000458	0.00116	CcSEcCtD
Esomeprazole—Anorexia—Lovastatin—atherosclerosis	0.000456	0.00116	CcSEcCtD
Esomeprazole—Skin disorder—Ezetimibe—atherosclerosis	0.000456	0.00116	CcSEcCtD
Esomeprazole—Angioedema—Pravastatin—atherosclerosis	0.000453	0.00115	CcSEcCtD
Esomeprazole—Vertigo—Niacin—atherosclerosis	0.000452	0.00115	CcSEcCtD
Esomeprazole—Confusional state—Simvastatin—atherosclerosis	0.000451	0.00114	CcSEcCtD
Esomeprazole—Leukopenia—Niacin—atherosclerosis	0.00045	0.00114	CcSEcCtD
Esomeprazole—Urticaria—Rosuvastatin—atherosclerosis	0.000448	0.00114	CcSEcCtD
Esomeprazole—Anaphylactic shock—Simvastatin—atherosclerosis	0.000447	0.00113	CcSEcCtD
Esomeprazole—Malaise—Pravastatin—atherosclerosis	0.000447	0.00113	CcSEcCtD
Esomeprazole—Abdominal pain—Rosuvastatin—atherosclerosis	0.000446	0.00113	CcSEcCtD
Esomeprazole—Vertigo—Pravastatin—atherosclerosis	0.000445	0.00113	CcSEcCtD
Esomeprazole—Palpitations—Niacin—atherosclerosis	0.000445	0.00113	CcSEcCtD
Esomeprazole—Infection—Simvastatin—atherosclerosis	0.000444	0.00113	CcSEcCtD
Esomeprazole—Leukopenia—Pravastatin—atherosclerosis	0.000444	0.00113	CcSEcCtD
Esomeprazole—ATP4A—Ion channel transport—TRPV1—atherosclerosis	0.000439	0.038	CbGpPWpGaD
Esomeprazole—Cough—Niacin—atherosclerosis	0.000439	0.00111	CcSEcCtD
Esomeprazole—Thrombocytopenia—Simvastatin—atherosclerosis	0.000438	0.00111	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000436	0.00111	CcSEcCtD
Esomeprazole—Insomnia—Lovastatin—atherosclerosis	0.000433	0.0011	CcSEcCtD
Esomeprazole—Cough—Pravastatin—atherosclerosis	0.000432	0.0011	CcSEcCtD
Esomeprazole—Paraesthesia—Lovastatin—atherosclerosis	0.000429	0.00109	CcSEcCtD
Esomeprazole—Arthralgia—Niacin—atherosclerosis	0.000428	0.00109	CcSEcCtD
Esomeprazole—Myalgia—Niacin—atherosclerosis	0.000428	0.00109	CcSEcCtD
Esomeprazole—Hypertension—Pravastatin—atherosclerosis	0.000428	0.00109	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000427	0.00108	CcSEcCtD
Esomeprazole—Anorexia—Simvastatin—atherosclerosis	0.000426	0.00108	CcSEcCtD
Esomeprazole—Dyspnoea—Lovastatin—atherosclerosis	0.000426	0.00108	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000426	0.00108	CcSEcCtD
Esomeprazole—Insomnia—Ezetimibe—atherosclerosis	0.000424	0.00108	CcSEcCtD
Esomeprazole—Myalgia—Pravastatin—atherosclerosis	0.000422	0.00107	CcSEcCtD
Esomeprazole—Chest pain—Pravastatin—atherosclerosis	0.000422	0.00107	CcSEcCtD
Esomeprazole—Arthralgia—Pravastatin—atherosclerosis	0.000422	0.00107	CcSEcCtD
Esomeprazole—Paraesthesia—Ezetimibe—atherosclerosis	0.000421	0.00107	CcSEcCtD
Esomeprazole—Dyspepsia—Lovastatin—atherosclerosis	0.000421	0.00107	CcSEcCtD
Esomeprazole—Anxiety—Pravastatin—atherosclerosis	0.00042	0.00107	CcSEcCtD
Esomeprazole—Dry mouth—Niacin—atherosclerosis	0.000419	0.00106	CcSEcCtD
Esomeprazole—Dyspnoea—Ezetimibe—atherosclerosis	0.000418	0.00106	CcSEcCtD
Esomeprazole—Discomfort—Pravastatin—atherosclerosis	0.000417	0.00106	CcSEcCtD
Esomeprazole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000416	0.00105	CcSEcCtD
Esomeprazole—Decreased appetite—Lovastatin—atherosclerosis	0.000416	0.00105	CcSEcCtD
Esomeprazole—Dyspepsia—Ezetimibe—atherosclerosis	0.000413	0.00105	CcSEcCtD
Esomeprazole—Fatigue—Lovastatin—atherosclerosis	0.000412	0.00105	CcSEcCtD
Esomeprazole—Anaphylactic shock—Niacin—atherosclerosis	0.000411	0.00104	CcSEcCtD
Esomeprazole—Constipation—Lovastatin—atherosclerosis	0.000409	0.00104	CcSEcCtD
Esomeprazole—Pain—Lovastatin—atherosclerosis	0.000409	0.00104	CcSEcCtD
Esomeprazole—Confusional state—Pravastatin—atherosclerosis	0.000408	0.00103	CcSEcCtD
Esomeprazole—Decreased appetite—Ezetimibe—atherosclerosis	0.000408	0.00103	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000408	0.00103	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000405	0.00103	CcSEcCtD
Esomeprazole—Asthenia—Rosuvastatin—atherosclerosis	0.000405	0.00103	CcSEcCtD
Esomeprazole—Insomnia—Simvastatin—atherosclerosis	0.000405	0.00103	CcSEcCtD
Esomeprazole—Anaphylactic shock—Pravastatin—atherosclerosis	0.000404	0.00103	CcSEcCtD
Esomeprazole—Fatigue—Ezetimibe—atherosclerosis	0.000404	0.00103	CcSEcCtD
Esomeprazole—Shock—Niacin—atherosclerosis	0.000404	0.00103	CcSEcCtD
Esomeprazole—Infection—Pravastatin—atherosclerosis	0.000402	0.00102	CcSEcCtD
Esomeprazole—Paraesthesia—Simvastatin—atherosclerosis	0.000402	0.00102	CcSEcCtD
Esomeprazole—Pain—Ezetimibe—atherosclerosis	0.000401	0.00102	CcSEcCtD
Esomeprazole—Constipation—Ezetimibe—atherosclerosis	0.000401	0.00102	CcSEcCtD
Esomeprazole—Tachycardia—Niacin—atherosclerosis	0.000401	0.00102	CcSEcCtD
Esomeprazole—Pruritus—Rosuvastatin—atherosclerosis	0.000399	0.00101	CcSEcCtD
Esomeprazole—Skin disorder—Niacin—atherosclerosis	0.000399	0.00101	CcSEcCtD
Esomeprazole—Dyspnoea—Simvastatin—atherosclerosis	0.000399	0.00101	CcSEcCtD
Esomeprazole—Hyperhidrosis—Niacin—atherosclerosis	0.000397	0.00101	CcSEcCtD
Esomeprazole—Thrombocytopenia—Pravastatin—atherosclerosis	0.000396	0.001	CcSEcCtD
Esomeprazole—Feeling abnormal—Lovastatin—atherosclerosis	0.000394	0.001	CcSEcCtD
Esomeprazole—Dyspepsia—Simvastatin—atherosclerosis	0.000394	0.000999	CcSEcCtD
Esomeprazole—Anorexia—Niacin—atherosclerosis	0.000392	0.000993	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000391	0.000992	CcSEcCtD
Esomeprazole—Hyperhidrosis—Pravastatin—atherosclerosis	0.000391	0.000992	CcSEcCtD
Esomeprazole—Decreased appetite—Simvastatin—atherosclerosis	0.000389	0.000986	CcSEcCtD
Esomeprazole—Feeling abnormal—Ezetimibe—atherosclerosis	0.000387	0.00098	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000386	0.00098	CcSEcCtD
Esomeprazole—Diarrhoea—Rosuvastatin—atherosclerosis	0.000386	0.000979	CcSEcCtD
Esomeprazole—Fatigue—Simvastatin—atherosclerosis	0.000386	0.000978	CcSEcCtD
Esomeprazole—Anorexia—Pravastatin—atherosclerosis	0.000385	0.000978	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000384	0.000973	CcSEcCtD
Esomeprazole—Pain—Simvastatin—atherosclerosis	0.000383	0.00097	CcSEcCtD
Esomeprazole—Constipation—Simvastatin—atherosclerosis	0.000383	0.00097	CcSEcCtD
Esomeprazole—Urticaria—Lovastatin—atherosclerosis	0.00038	0.000964	CcSEcCtD
Esomeprazole—Abdominal pain—Lovastatin—atherosclerosis	0.000378	0.000959	CcSEcCtD
Esomeprazole—Body temperature increased—Lovastatin—atherosclerosis	0.000378	0.000959	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000374	0.000949	CcSEcCtD
Esomeprazole—Dizziness—Rosuvastatin—atherosclerosis	0.000373	0.000947	CcSEcCtD
Esomeprazole—Urticaria—Ezetimibe—atherosclerosis	0.000373	0.000945	CcSEcCtD
Esomeprazole—Insomnia—Niacin—atherosclerosis	0.000371	0.000942	CcSEcCtD
Esomeprazole—Abdominal pain—Ezetimibe—atherosclerosis	0.000371	0.000941	CcSEcCtD
Esomeprazole—Body temperature increased—Ezetimibe—atherosclerosis	0.000371	0.000941	CcSEcCtD
Esomeprazole—Paraesthesia—Niacin—atherosclerosis	0.000369	0.000936	CcSEcCtD
Esomeprazole—Feeling abnormal—Simvastatin—atherosclerosis	0.000369	0.000935	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000368	0.000935	CcSEcCtD
Esomeprazole—Dyspnoea—Niacin—atherosclerosis	0.000366	0.000929	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000366	0.000928	CcSEcCtD
Esomeprazole—Insomnia—Pravastatin—atherosclerosis	0.000366	0.000928	CcSEcCtD
Esomeprazole—Somnolence—Niacin—atherosclerosis	0.000365	0.000926	CcSEcCtD
Esomeprazole—Paraesthesia—Pravastatin—atherosclerosis	0.000363	0.000921	CcSEcCtD
Esomeprazole—Dyspepsia—Niacin—atherosclerosis	0.000362	0.000917	CcSEcCtD
Esomeprazole—Dyspnoea—Pravastatin—atherosclerosis	0.000361	0.000915	CcSEcCtD
Esomeprazole—Decreased appetite—Niacin—atherosclerosis	0.000357	0.000906	CcSEcCtD
Esomeprazole—Dyspepsia—Pravastatin—atherosclerosis	0.000356	0.000903	CcSEcCtD
Esomeprazole—Rash—Rosuvastatin—atherosclerosis	0.000356	0.000903	CcSEcCtD
Esomeprazole—Dermatitis—Rosuvastatin—atherosclerosis	0.000355	0.000902	CcSEcCtD
Esomeprazole—Urticaria—Simvastatin—atherosclerosis	0.000355	0.000901	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Niacin—atherosclerosis	0.000355	0.000899	CcSEcCtD
Esomeprazole—Body temperature increased—Simvastatin—atherosclerosis	0.000354	0.000897	CcSEcCtD
Esomeprazole—Abdominal pain—Simvastatin—atherosclerosis	0.000354	0.000897	CcSEcCtD
Esomeprazole—Headache—Rosuvastatin—atherosclerosis	0.000354	0.000897	CcSEcCtD
Esomeprazole—CYP3A4—Liver X Receptor Pathway—CYP7A1—atherosclerosis	0.000353	0.0305	CbGpPWpGaD
Esomeprazole—Hypersensitivity—Lovastatin—atherosclerosis	0.000352	0.000894	CcSEcCtD
Esomeprazole—Decreased appetite—Pravastatin—atherosclerosis	0.000352	0.000892	CcSEcCtD
Esomeprazole—Pain—Niacin—atherosclerosis	0.000351	0.000891	CcSEcCtD
Esomeprazole—Fatigue—Pravastatin—atherosclerosis	0.000349	0.000884	CcSEcCtD
Esomeprazole—Constipation—Pravastatin—atherosclerosis	0.000346	0.000877	CcSEcCtD
Esomeprazole—Pain—Pravastatin—atherosclerosis	0.000346	0.000877	CcSEcCtD
Esomeprazole—Hypersensitivity—Ezetimibe—atherosclerosis	0.000346	0.000877	CcSEcCtD
Esomeprazole—Asthenia—Lovastatin—atherosclerosis	0.000343	0.00087	CcSEcCtD
Esomeprazole—Pruritus—Lovastatin—atherosclerosis	0.000338	0.000858	CcSEcCtD
Esomeprazole—Asthenia—Ezetimibe—atherosclerosis	0.000337	0.000854	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Niacin—atherosclerosis	0.000336	0.000852	CcSEcCtD
Esomeprazole—Nausea—Rosuvastatin—atherosclerosis	0.000335	0.00085	CcSEcCtD
Esomeprazole—Feeling abnormal—Pravastatin—atherosclerosis	0.000333	0.000845	CcSEcCtD
Esomeprazole—Pruritus—Ezetimibe—atherosclerosis	0.000332	0.000842	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000331	0.000839	CcSEcCtD
Esomeprazole—Hypersensitivity—Simvastatin—atherosclerosis	0.00033	0.000836	CcSEcCtD
Esomeprazole—Diarrhoea—Lovastatin—atherosclerosis	0.000327	0.00083	CcSEcCtD
Esomeprazole—Urticaria—Niacin—atherosclerosis	0.000326	0.000828	CcSEcCtD
Esomeprazole—Body temperature increased—Niacin—atherosclerosis	0.000325	0.000824	CcSEcCtD
Esomeprazole—Abdominal pain—Niacin—atherosclerosis	0.000325	0.000824	CcSEcCtD
Esomeprazole—Urticaria—Pravastatin—atherosclerosis	0.000321	0.000815	CcSEcCtD
Esomeprazole—Asthenia—Simvastatin—atherosclerosis	0.000321	0.000814	CcSEcCtD
Esomeprazole—Diarrhoea—Ezetimibe—atherosclerosis	0.000321	0.000814	CcSEcCtD
Esomeprazole—Abdominal pain—Pravastatin—atherosclerosis	0.00032	0.000811	CcSEcCtD
Esomeprazole—Body temperature increased—Pravastatin—atherosclerosis	0.00032	0.000811	CcSEcCtD
Esomeprazole—Pruritus—Simvastatin—atherosclerosis	0.000316	0.000803	CcSEcCtD
Esomeprazole—Dizziness—Lovastatin—atherosclerosis	0.000316	0.000802	CcSEcCtD
Esomeprazole—Dizziness—Ezetimibe—atherosclerosis	0.00031	0.000787	CcSEcCtD
Esomeprazole—Diarrhoea—Simvastatin—atherosclerosis	0.000306	0.000776	CcSEcCtD
Esomeprazole—CYP3A4—Liver X Receptor Pathway—ABCG5—atherosclerosis	0.000305	0.0264	CbGpPWpGaD
Esomeprazole—Vomiting—Lovastatin—atherosclerosis	0.000304	0.000771	CcSEcCtD
Esomeprazole—Hypersensitivity—Niacin—atherosclerosis	0.000303	0.000768	CcSEcCtD
Esomeprazole—Rash—Lovastatin—atherosclerosis	0.000302	0.000765	CcSEcCtD
Esomeprazole—Dermatitis—Lovastatin—atherosclerosis	0.000301	0.000764	CcSEcCtD
Esomeprazole—Headache—Lovastatin—atherosclerosis	0.0003	0.00076	CcSEcCtD
Esomeprazole—Vomiting—Ezetimibe—atherosclerosis	0.000298	0.000757	CcSEcCtD
Esomeprazole—Hypersensitivity—Pravastatin—atherosclerosis	0.000298	0.000756	CcSEcCtD
Esomeprazole—Dizziness—Simvastatin—atherosclerosis	0.000296	0.00075	CcSEcCtD
Esomeprazole—Rash—Ezetimibe—atherosclerosis	0.000296	0.00075	CcSEcCtD
Esomeprazole—Dermatitis—Ezetimibe—atherosclerosis	0.000295	0.00075	CcSEcCtD
Esomeprazole—Asthenia—Niacin—atherosclerosis	0.000295	0.000748	CcSEcCtD
Esomeprazole—Headache—Ezetimibe—atherosclerosis	0.000294	0.000745	CcSEcCtD
Esomeprazole—Pruritus—Niacin—atherosclerosis	0.000291	0.000737	CcSEcCtD
Esomeprazole—Asthenia—Pravastatin—atherosclerosis	0.00029	0.000736	CcSEcCtD
Esomeprazole—Pruritus—Pravastatin—atherosclerosis	0.000286	0.000726	CcSEcCtD
Esomeprazole—Vomiting—Simvastatin—atherosclerosis	0.000284	0.000721	CcSEcCtD
Esomeprazole—Nausea—Lovastatin—atherosclerosis	0.000284	0.000721	CcSEcCtD
Esomeprazole—Rash—Simvastatin—atherosclerosis	0.000282	0.000715	CcSEcCtD
Esomeprazole—Dermatitis—Simvastatin—atherosclerosis	0.000282	0.000715	CcSEcCtD
Esomeprazole—Diarrhoea—Niacin—atherosclerosis	0.000281	0.000713	CcSEcCtD
Esomeprazole—Headache—Simvastatin—atherosclerosis	0.00028	0.000711	CcSEcCtD
Esomeprazole—Nausea—Ezetimibe—atherosclerosis	0.000279	0.000707	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000278	0.024	CbGpPWpGaD
Esomeprazole—Diarrhoea—Pravastatin—atherosclerosis	0.000277	0.000702	CcSEcCtD
Esomeprazole—Dizziness—Niacin—atherosclerosis	0.000272	0.000689	CcSEcCtD
Esomeprazole—Dizziness—Pravastatin—atherosclerosis	0.000267	0.000678	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000266	0.023	CbGpPWpGaD
Esomeprazole—Nausea—Simvastatin—atherosclerosis	0.000266	0.000674	CcSEcCtD
Esomeprazole—Vomiting—Niacin—atherosclerosis	0.000261	0.000662	CcSEcCtD
Esomeprazole—Rash—Niacin—atherosclerosis	0.000259	0.000657	CcSEcCtD
Esomeprazole—Dermatitis—Niacin—atherosclerosis	0.000259	0.000656	CcSEcCtD
Esomeprazole—Headache—Niacin—atherosclerosis	0.000257	0.000653	CcSEcCtD
Esomeprazole—Vomiting—Pravastatin—atherosclerosis	0.000257	0.000652	CcSEcCtD
Esomeprazole—Rash—Pravastatin—atherosclerosis	0.000255	0.000647	CcSEcCtD
Esomeprazole—Dermatitis—Pravastatin—atherosclerosis	0.000255	0.000646	CcSEcCtD
Esomeprazole—Headache—Pravastatin—atherosclerosis	0.000253	0.000643	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000248	0.0214	CbGpPWpGaD
Esomeprazole—Nausea—Niacin—atherosclerosis	0.000244	0.000619	CcSEcCtD
Esomeprazole—Nausea—Pravastatin—atherosclerosis	0.00024	0.000609	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000237	0.0205	CbGpPWpGaD
Esomeprazole—CYP3A4—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.000231	0.0199	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—LTA4H—atherosclerosis	0.000226	0.0195	CbGpPWpGaD
Esomeprazole—CYP3A4—Farnesoid X Receptor  Pathway—CYP7A1—atherosclerosis	0.000211	0.0182	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00021	0.0182	CbGpPWpGaD
Esomeprazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.000194	0.0167	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000191	0.0165	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000188	0.0162	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000172	0.0148	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.00017	0.0147	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000165	0.0143	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000153	0.0132	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000147	0.0127	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000146	0.0126	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—ALOX5AP—atherosclerosis	0.000142	0.0122	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—ALOX15—atherosclerosis	0.000142	0.0122	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.00014	0.0121	CbGpPWpGaD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000138	0.0119	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000132	0.0114	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000129	0.0112	CbGpPWpGaD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000128	0.011	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000122	0.0106	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—ALOX5—atherosclerosis	0.000121	0.0104	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000115	0.00991	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000113	0.00979	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000109	0.00941	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000108	0.00931	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000105	0.00905	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—EDN1—atherosclerosis	0.000104	0.00903	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—PLAT—atherosclerosis	9.6e-05	0.0083	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—PLG—atherosclerosis	9.16e-05	0.00792	CbGpPWpGaD
Esomeprazole—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	9.1e-05	0.00786	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—APOE—atherosclerosis	8.5e-05	0.00734	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—HMOX1—atherosclerosis	8.45e-05	0.0073	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	8.41e-05	0.00727	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	8.3e-05	0.00717	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—PLG—atherosclerosis	8.16e-05	0.00705	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—APOB—atherosclerosis	8.1e-05	0.007	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	7.77e-05	0.00672	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	7.67e-05	0.00663	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—HMOX1—atherosclerosis	7.54e-05	0.00651	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—APOB—atherosclerosis	7.22e-05	0.00624	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	6.84e-05	0.00591	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—PPARA—atherosclerosis	6.83e-05	0.0059	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	6.82e-05	0.00589	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.41e-05	0.00554	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—GPX1—atherosclerosis	6.4e-05	0.00553	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	6.3e-05	0.00544	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—PPARA—atherosclerosis	6.09e-05	0.00526	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP7A1—atherosclerosis	6.02e-05	0.0052	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP7A1—atherosclerosis	5.94e-05	0.00513	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.71e-05	0.00493	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP27A1—atherosclerosis	5.57e-05	0.00481	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP27A1—atherosclerosis	5.49e-05	0.00474	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ALB—atherosclerosis	5.08e-05	0.00439	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—NFKB1—atherosclerosis	5.05e-05	0.00437	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	4.74e-05	0.0041	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ALB—atherosclerosis	4.52e-05	0.00391	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	3.96e-05	0.00342	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	3.92e-05	0.00339	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—atherosclerosis	3.77e-05	0.00325	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	3.72e-05	0.00322	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	3.62e-05	0.00313	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	3.57e-05	0.00309	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	3.35e-05	0.00289	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	3.3e-05	0.00285	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	3.23e-05	0.00279	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	3.23e-05	0.00279	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	2.55e-05	0.0022	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—GSTM1—atherosclerosis	2.49e-05	0.00215	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—GSTM1—atherosclerosis	2.45e-05	0.00212	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	2.4e-05	0.00207	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	2.4e-05	0.00207	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	2.35e-05	0.00203	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	2.31e-05	0.002	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	2.14e-05	0.00185	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	2.03e-05	0.00175	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	2.03e-05	0.00175	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	2.03e-05	0.00175	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	2.03e-05	0.00175	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	2e-05	0.00173	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	1.93e-05	0.00167	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	1.85e-05	0.0016	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	1.78e-05	0.00154	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LDLRAP1—atherosclerosis	1.76e-05	0.00152	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.72e-05	0.00149	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLTP—atherosclerosis	1.66e-05	0.00143	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.54e-05	0.00133	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.53e-05	0.00132	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.52e-05	0.00131	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	1.49e-05	0.00129	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.48e-05	0.00128	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.47e-05	0.00127	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LTA4H—atherosclerosis	1.44e-05	0.00124	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCG8—atherosclerosis	1.44e-05	0.00124	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.42e-05	0.00123	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.34e-05	0.00116	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.19e-05	0.00103	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCG1—atherosclerosis	1.14e-05	0.000981	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LCAT—atherosclerosis	1.07e-05	0.000923	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—FABP4—atherosclerosis	1.07e-05	0.000923	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.06e-05	0.000916	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA4—atherosclerosis	1.05e-05	0.000906	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP7A1—atherosclerosis	1.03e-05	0.00089	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLTP—atherosclerosis	9.97e-06	0.000861	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	9.81e-06	0.000848	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP27A1—atherosclerosis	9.52e-06	0.000822	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	9.37e-06	0.00081	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	9.14e-06	0.00079	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA2—atherosclerosis	9.02e-06	0.00078	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	9.02e-06	0.00078	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALOX15—atherosclerosis	9.02e-06	0.00078	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	9.02e-06	0.00078	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCG5—atherosclerosis	8.91e-06	0.00077	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	8.9e-06	0.000769	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCG8—atherosclerosis	8.64e-06	0.000747	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LTA4H—atherosclerosis	8.64e-06	0.000747	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LPA—atherosclerosis	8.61e-06	0.000744	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—BGN—atherosclerosis	8.34e-06	0.00072	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.28e-06	0.000715	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA5—atherosclerosis	8.25e-06	0.000713	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.02e-06	0.000693	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	7.94e-06	0.000686	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.85e-06	0.000679	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.78e-06	0.000672	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.76e-06	0.000671	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALOX5—atherosclerosis	7.67e-06	0.000663	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.09e-06	0.000612	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NAMPT—atherosclerosis	6.88e-06	0.000595	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.84e-06	0.000591	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LIPC—atherosclerosis	6.84e-06	0.000591	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCG1—atherosclerosis	6.83e-06	0.00059	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOC3—atherosclerosis	6.8e-06	0.000587	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LDLR—atherosclerosis	6.75e-06	0.000584	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CETP—atherosclerosis	6.6e-06	0.00057	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—FABP4—atherosclerosis	6.42e-06	0.000555	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LCAT—atherosclerosis	6.42e-06	0.000555	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SCARB1—atherosclerosis	6.32e-06	0.000546	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA4—atherosclerosis	6.3e-06	0.000545	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP7A1—atherosclerosis	6.19e-06	0.000535	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.15e-06	0.000532	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMGCR—atherosclerosis	5.97e-06	0.000516	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP27A1—atherosclerosis	5.72e-06	0.000495	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.43e-06	0.000469	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.43e-06	0.000469	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA2—atherosclerosis	5.43e-06	0.000469	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.43e-06	0.000469	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.38e-06	0.000465	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.36e-06	0.000463	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCA1—atherosclerosis	5.32e-06	0.000459	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LPA—atherosclerosis	5.18e-06	0.000447	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—BGN—atherosclerosis	5.01e-06	0.000433	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA5—atherosclerosis	4.96e-06	0.000429	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.78e-06	0.000413	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.61e-06	0.000399	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMOX1—atherosclerosis	4.56e-06	0.000394	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOB—atherosclerosis	4.37e-06	0.000378	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTM1—atherosclerosis	4.25e-06	0.000367	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LPL—atherosclerosis	4.17e-06	0.000361	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.14e-06	0.000358	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LIPC—atherosclerosis	4.11e-06	0.000355	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOC3—atherosclerosis	4.09e-06	0.000353	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPX1—atherosclerosis	4.07e-06	0.000352	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LDLR—atherosclerosis	4.06e-06	0.000351	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CETP—atherosclerosis	3.97e-06	0.000343	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CD36—atherosclerosis	3.97e-06	0.000343	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.8e-06	0.000328	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MTHFR—atherosclerosis	3.76e-06	0.000325	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARA—atherosclerosis	3.69e-06	0.000318	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.59e-06	0.00031	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AGT—atherosclerosis	3.57e-06	0.000308	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOE—atherosclerosis	3.5e-06	0.000302	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CAV1—atherosclerosis	3.47e-06	0.000299	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA1—atherosclerosis	3.46e-06	0.000299	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.2e-06	0.000276	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.16e-06	0.000273	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARG—atherosclerosis	3.05e-06	0.000263	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—INS—atherosclerosis	2.99e-06	0.000258	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.74e-06	0.000237	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALB—atherosclerosis	2.74e-06	0.000237	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOB—atherosclerosis	2.63e-06	0.000227	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NOS3—atherosclerosis	2.62e-06	0.000226	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.56e-06	0.000221	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LPL—atherosclerosis	2.51e-06	0.000217	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPX1—atherosclerosis	2.45e-06	0.000212	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.4e-06	0.000207	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CD36—atherosclerosis	2.38e-06	0.000206	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.26e-06	0.000195	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARA—atherosclerosis	2.22e-06	0.000192	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AGT—atherosclerosis	2.15e-06	0.000185	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOE—atherosclerosis	2.1e-06	0.000182	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CAV1—atherosclerosis	2.08e-06	0.00018	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA1—atherosclerosis	2.08e-06	0.00018	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.9e-06	0.000164	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARG—atherosclerosis	1.83e-06	0.000158	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—INS—atherosclerosis	1.8e-06	0.000155	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALB—atherosclerosis	1.65e-06	0.000142	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NOS3—atherosclerosis	1.58e-06	0.000136	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.44e-06	0.000125	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKT1—atherosclerosis	1.2e-06	0.000104	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKT1—atherosclerosis	7.24e-07	6.26e-05	CbGpPWpGaD
